PortfoliosLab logoPortfoliosLab logo
LOOP vs. DMAC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LOOP vs. DMAC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loop Industries, Inc. (LOOP) and DiaMedica Therapeutics Inc. (DMAC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LOOP achieves a -27.03% return, which is significantly lower than DMAC's -20.35% return.


LOOP

1D
-0.05%
1M
-19.22%
6M
-39.69%
YTD
-27.03%
1Y
-52.31%
3Y*
-38.19%
5Y*
-41.31%
10Y*
ALL TIME*
-29.10%

DMAC

1D
-2.61%
1M
-16.80%
6M
-21.14%
YTD
-20.35%
1Y
53.88%
3Y*
24.82%
5Y*
12.94%
10Y*
4.82%
ALL TIME*
-7.31%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.23M$1.52M$1.36M
$65.43K$74.02K$77.94K

LOOP vs. DMAC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LOOP
Loop Industries, Inc.
-27.03%-16.67%-68.25%58.16%-80.52%47.83%-16.16%27.41%-46.34%-0.14%
DMAC
DiaMedica Therapeutics Inc.
-20.35%46.59%91.20%79.74%-57.64%-63.21%109.07%66.67%-41.80%-19.35%

Correlation

The correlation between LOOP and DMAC is 0.17, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.17

Correlation (3Y)
Balances recent behavior with more history.

0.05

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.10

Correlation (All Time)
Calculated using the full available price history since Nov 20, 2017

0.08

The correlation between LOOP and DMAC shifts across timeframes, from 0.05 (3 years) to 0.17 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

LOOP:

$35.30M

DMAC:

$341.62M

EPS

LOOP:

-$0.25

DMAC:

-$0.70

Total Revenue (TTM)

LOOP:

$441.00K

DMAC:

$0.00

Gross Profit (TTM)

LOOP:

-$23.00K

DMAC:

-$11.00K

EBITDA (TTM)

LOOP:

-$6.90M

DMAC:

-$36.69M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Loop Industries, Inc.

DiaMedica Therapeutics Inc.

Return for Risk

LOOP vs. DMAC — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

LOOP
LOOP Risk / Return Rank: 1212
Overall Rank
LOOP Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
LOOP Sortino Ratio Rank: 1414
Sortino Ratio Rank
LOOP Omega Ratio Rank: 1515
Omega Ratio Rank
LOOP Calmar Ratio Rank: 1010
Calmar Ratio Rank
LOOP Martin Ratio Rank: 88
Martin Ratio Rank

DMAC
DMAC Risk / Return Rank: 7070
Overall Rank
DMAC Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
DMAC Sortino Ratio Rank: 7272
Sortino Ratio Rank
DMAC Omega Ratio Rank: 6969
Omega Ratio Rank
DMAC Calmar Ratio Rank: 7070
Calmar Ratio Rank
DMAC Martin Ratio Rank: 6767
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

LOOP vs. DMAC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loop Industries, Inc. (LOOP) and DiaMedica Therapeutics Inc. (DMAC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LOOPDMACDifference
Sharpe ratioReturn per unit of total volatility

-1.51

Sortino ratioReturn per unit of downside risk

-2.49

Omega ratioGain probability vs. loss probability

0.89

1.18

-0.29

Calmar ratioReturn relative to maximum drawdown

-0.85

1.17

-2.02

Martin ratioReturn relative to average drawdown

-1.42

2.40

-3.81

LOOP vs. DMAC - Sharpe Ratio Comparison

The current LOOP Sharpe Ratio is -0.71, which is lower than the DMAC Sharpe Ratio of 0.80. The chart below compares the historical Sharpe Ratios of LOOP and DMAC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LOOP vs. DMAC - Drawdown Comparison

The maximum LOOP drawdown since its inception was -96.00%, roughly equal to the maximum DMAC drawdown of -98.16%. Use the drawdown chart below to compare losses from any high point for LOOP and DMAC.


Loading charts...

Drawdown Indicators


LOOPDMACDifference

Max Drawdown

Largest peak-to-trough decline

-96.00%

-98.16%

+2.16%

Max Drawdown (1Y)

Largest decline over 1 year

-65.04%

-43.24%

-21.80%

Max Drawdown (3Y)

Largest decline over 3 years

-83.85%

-49.17%

-34.68%

Max Drawdown (5Y)

Largest decline over 5 years

-95.93%

-75.70%

-20.23%

Max Drawdown (10Y)

Largest decline over 10 years

-91.60%

Current Drawdown

Current decline from peak

-95.95%

-85.65%

-10.30%

Average Drawdown

Average peak-to-trough decline

-63.55%

-71.47%

+7.92%

Ulcer Index

Depth and duration of drawdowns from previous peaks

39.02%

21.03%

+17.99%

Volatility

LOOP vs. DMAC - Volatility Comparison

Loop Industries, Inc. (LOOP) has a higher volatility of 33.92% compared to DiaMedica Therapeutics Inc. (DMAC) at 13.16%. This indicates that LOOP's price experiences larger fluctuations and is considered to be riskier than DMAC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LOOPDMACDifference

Volatility (1M)

Calculated over the trailing 1-month period

33.92%

13.16%

+20.76%

Volatility (6M)

Calculated over the trailing 6-month period

56.84%

35.91%

+20.93%

Volatility (1Y)

Calculated over the trailing 1-year period

78.10%

63.25%

+14.85%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

84.20%

75.13%

+9.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

78.95%

85.70%

-6.75%

Dividends

LOOP vs. DMAC - Dividend Comparison

Neither LOOP nor DMAC has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

LOOP vs. DMAC - Financials Comparison

This section allows you to compare key financial metrics between Loop Industries, Inc. and DiaMedica Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


LOOP and DMAC have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LOOP has higher volatility (33.92%) compared to DMAC (13.16%). In terms of maximum drawdown, LOOP dropped -96.00% vs DMAC's -98.16%.

DMAC currently has the higher Sharpe Ratio (0.80 vs -0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LOOP and DMAC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer